case_images: PMC10637777_01
case_images: Time to MSCC - case 1 (a); case 2 (b); case 3 (c); case 4 (d). The x-axis represents the number of days since starting enzalutamide. The y-axis represents PSA level. The plots indicate the PSA level on a specific day. Red dotted line indicates the day of spinal cord compression diagnosis.
case_images: cro-2023-0016-0001-534685_F01.jpg
case_images: PMC10637777_04_cro-2023-0016-0001-534685_F01.jpg
case_images: F1
case_images: In January 2013, he developed bone and lymph node metastases and he was commenced on enzalutamide with a fall in PSA from 64 mug/mL to 34 mug/mL (Fig. 1d).
case_images: Sagittal T2 weighted sequence MRI spine. a Low T2 signal soft tissue mass involving spinal cord and CSF space at T6 level (yellow arrow) on the background of extensive vertebral body metastatic disease. b Low T2 signal soft tissue mass at T7 level with extensive epidural space extension, spinal canal stenosis, and spinal cord compression (yellow arrow). c Large soft tissue mass centered on epidural space in T7 and T8 causing severe cord compression (yellow arrow). A soft tissue mass extending into posterior epidural space at L3 level (blue arrow). d Large epidural mass at T10 level causing complete canal block (yellow arrow).
case_images: cro-2023-0016-0001-534685_F02.jpg
case_images: PMC10637777_04_cro-2023-0016-0001-534685_F02.jpg
case_images: F2
case_images: T10 epidural mass with cord compression (Fig. 2d). The patient was treated with urgent radiotherapy and then commenced on docetaxel with good disease control.
case_images: PMC10637777_02
case_images: Time to MSCC - case 1 (a); case 2 (b); case 3 (c); case 4 (d). The x-axis represents the number of days since starting enzalutamide. The y-axis represents PSA level. The plots indicate the PSA level on a specific day. Red dotted line indicates the day of spinal cord compression diagnosis.
case_images: cro-2023-0016-0001-534685_F01.jpg
case_images: PMC10637777_04_cro-2023-0016-0001-534685_F01.jpg
case_images: F1
case_images: In January 2013, he developed bone and lymph node metastases and he was commenced on enzalutamide with a fall in PSA from 64 mug/mL to 34 mug/mL (Fig. 1d).
case_images: Sagittal T2 weighted sequence MRI spine. a Low T2 signal soft tissue mass involving spinal cord and CSF space at T6 level (yellow arrow) on the background of extensive vertebral body metastatic disease. b Low T2 signal soft tissue mass at T7 level with extensive epidural space extension, spinal canal stenosis, and spinal cord compression (yellow arrow). c Large soft tissue mass centered on epidural space in T7 and T8 causing severe cord compression (yellow arrow). A soft tissue mass extending into posterior epidural space at L3 level (blue arrow). d Large epidural mass at T10 level causing complete canal block (yellow arrow).
case_images: cro-2023-0016-0001-534685_F02.jpg
case_images: PMC10637777_04_cro-2023-0016-0001-534685_F02.jpg
case_images: F2
case_images: T10 epidural mass with cord compression (Fig. 2d). The patient was treated with urgent radiotherapy and then commenced on docetaxel with good disease control.
case_images: PMC10637777_03
case_images: Time to MSCC - case 1 (a); case 2 (b); case 3 (c); case 4 (d). The x-axis represents the number of days since starting enzalutamide. The y-axis represents PSA level. The plots indicate the PSA level on a specific day. Red dotted line indicates the day of spinal cord compression diagnosis.
case_images: cro-2023-0016-0001-534685_F01.jpg
case_images: PMC10637777_04_cro-2023-0016-0001-534685_F01.jpg
case_images: F1
case_images: In January 2013, he developed bone and lymph node metastases and he was commenced on enzalutamide with a fall in PSA from 64 mug/mL to 34 mug/mL (Fig. 1d).
case_images: Sagittal T2 weighted sequence MRI spine. a Low T2 signal soft tissue mass involving spinal cord and CSF space at T6 level (yellow arrow) on the background of extensive vertebral body metastatic disease. b Low T2 signal soft tissue mass at T7 level with extensive epidural space extension, spinal canal stenosis, and spinal cord compression (yellow arrow). c Large soft tissue mass centered on epidural space in T7 and T8 causing severe cord compression (yellow arrow). A soft tissue mass extending into posterior epidural space at L3 level (blue arrow). d Large epidural mass at T10 level causing complete canal block (yellow arrow).
case_images: cro-2023-0016-0001-534685_F02.jpg
case_images: PMC10637777_04_cro-2023-0016-0001-534685_F02.jpg
case_images: F2
case_images: T10 epidural mass with cord compression (Fig. 2d). The patient was treated with urgent radiotherapy and then commenced on docetaxel with good disease control.
case_images: PMC10637777_04
case_images: Time to MSCC - case 1 (a); case 2 (b); case 3 (c); case 4 (d). The x-axis represents the number of days since starting enzalutamide. The y-axis represents PSA level. The plots indicate the PSA level on a specific day. Red dotted line indicates the day of spinal cord compression diagnosis.
case_images: cro-2023-0016-0001-534685_F01.jpg
case_images: PMC10637777_04_cro-2023-0016-0001-534685_F01.jpg
case_images: F1
case_images: In January 2013, he developed bone and lymph node metastases and he was commenced on enzalutamide with a fall in PSA from 64 mug/mL to 34 mug/mL (Fig. 1d).
case_images: Sagittal T2 weighted sequence MRI spine. a Low T2 signal soft tissue mass involving spinal cord and CSF space at T6 level (yellow arrow) on the background of extensive vertebral body metastatic disease. b Low T2 signal soft tissue mass at T7 level with extensive epidural space extension, spinal canal stenosis, and spinal cord compression (yellow arrow). c Large soft tissue mass centered on epidural space in T7 and T8 causing severe cord compression (yellow arrow). A soft tissue mass extending into posterior epidural space at L3 level (blue arrow). d Large epidural mass at T10 level causing complete canal block (yellow arrow).
case_images: cro-2023-0016-0001-534685_F02.jpg
case_images: PMC10637777_04_cro-2023-0016-0001-534685_F02.jpg
case_images: F2
case_images: T10 epidural mass with cord compression (Fig. 2d). The patient was treated with urgent radiotherapy and then commenced on docetaxel with good disease control.